This is a preview of subscription content, log in via an institution to check access.
References
Ritchie JL, Bateman TM, Bonow RO, et al. Guidelines for clinical use of cardiac radionuclide imaging: report of the American College of Cardiology/American Heart Association Task force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology. J Am Coll Cardiol. 1995; 25: 521–547
Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: a report of the American Collage of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography), developed in collaboration with the American Society of Echocardiography. Circulation, 1997; 95: 1686–1744
Gibbons RJ, Beasley JW, Bricker JT, et al. ACC/AHA guidelines for exercise testing: a report of the American College of Cardiolog American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol. 1997; 30: 260–311
Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J. am Coll Cardiol. In press
Dajani AS, Taubert KA, Wilson W, et al. Prevention, of bacterial endocarditis: recommendations by the American Heart Association. Circulation. 1997; 96: 358–366
Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals: Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association, Pediatrics. 1995; 96: 758–764
Cheitlin MD, Douglas PS, Parmley WW. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. J Am Coll Cardiol. 1994; 24: 874–880
From the Centers for Disease Control and Prevention. Cardiac valvulopathy associated with exposure to fenfluramine and dexfenfluramine: US Department Health and Human Services interim public health recommendations, November 1997, JAMA. 1997; 278: 1729–1731
Wilson WR, Karchmer AW, Dajani As, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms: American Heart Association. JAMA. 1995; 274: 1706–1713
Additional information
Reprinted with permission from the publishers
Circulation 1998; 98: 1949–1984
Rights and permissions
About this article
Cite this article
Bonow, R.O., Carabello, B., de Leon, A.C. et al. Guidelines for the management of patients with valvular heart disease: executive summary. Indian J Thorac Cardiovasc Surg 16, 30–73 (2000). https://doi.org/10.1007/s12055-000-0010-9
Issue Date:
DOI: https://doi.org/10.1007/s12055-000-0010-9